Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Autosomal recessive variants in PYCR2 cause Hypomyelinating Leukodystrophy 10, a white-matter disorder marked by CNS hypomyelination, postnatal microcephaly, and global developmental delay. Initial linkage in two consanguineous families and whole-exome sequencing in a single proband established a homozygous nonsense mutation in PYCR2 as disease-causing (PMID:25865492). Subsequent reports have now described at least 11 affected individuals across five unrelated families, including a recurrent c.400G>A (p.Val134Met) founder variant in Thai patients (1 proband (PMID:37228935); 2 probands (PMID:34037307); 5 probands (PMID:27860360); 3 probands (PMID:38709052)).
All patients exhibit autosomal recessive inheritance with both missense and loss-of-function allele classes. Documented variants include nonsense (e.g., c.28C>T (p.Gln10Ter)), splice-site and frameshift alleles, and recurrent missense changes such as c.400G>A (p.Val134Met) and c.355C>T (p.Arg119Cys) (PMID:27860360; PMID:33771508). The c.400G>A variant shows a 2.3 Mb shared haplotype suggesting a ~1,450-year-old founder effect in Thai families (PMID:34037307).
Clinically, core features across cohorts include progressive microcephaly, global developmental delay, hypotonia with peripheral spasticity, facial dysmorphism, movement disorders, seizures, failure to thrive, and hypomyelination or delayed myelination on brain MRI (PMID:27860360; PMID:34037307). A single case report noted additional systemic features of diarrhea and febrile convulsions (PMID:37228935).
Cellular and biochemical assays demonstrate that PYCR2 variant proteins are unstable, with reduced steady-state levels in patient lymphoblasts and HEK293FT cells and normal mitochondrial targeting but increased apoptosis under oxidative stress (PMID:25865492). Morpholino knockdown of the zebrafish PYCR2 ortholog recapitulates microcephaly and white-matter defects, which are rescued by wild-type but not mutant human PYCR2 mRNAs (PMID:25865492).
Enzyme kinetics of missense variants Arg119Cys and Arg251Cys reveal 40–366× and 7–26× reductions in catalytic efficiency, respectively, confirming loss-of-function (PMID:33771508). Untargeted metabolomics shows normal proline levels but perturbations in purine/pyrimidine pathways (PMID:38709052). In FBD-102b oligodendroglial cultures, mutant R119C and R251C proteins induce enlarged mitochondria, decreased fission, and impaired morphological differentiation (PMID:36548190). Pycr2 knockout mice mirror human pathology with neurodegeneration, excess cerebral glycine via SHMT2 upregulation, and partial rescue upon SHMT2 knockdown (PMID:32330411).
Overall, the convergence of robust segregation in multiple families, a spectrum of recessive PYCR2 variants, consistent biochemical impairment, and animal and cellular models supports a Strong gene–disease association. PYCR2 sequencing should be included in leukodystrophy diagnostic panels, and metabolic modulation of glycine offers a promising therapeutic avenue.
Gene–Disease AssociationStrong11 probands (PMID:37228935; PMID:34037307; PMID:27860360; PMID:38709052), co-segregation in 5 affected relatives (PMID:27860360), concordant functional and animal model studies (PMID:25865492; PMID:32330411) Genetic EvidenceStrongAutosomal recessive with 11 probands, multiple consanguineous families, recurrent founder c.400G>A (p.Val134Met) Functional EvidenceStrongBiochemical impairment in variant enzymes and stability assays (PMID:33771508; PMID:25865492), zebrafish rescue (PMID:25865492), mouse model and glycine pathway rescue (PMID:32330411) |